
OMEROS CORP — Investor Relations & Filings
Omeros Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company leverages innovative science to build a diverse pipeline of first-in-class drug candidates designed to address challenging diseases and disorders with significant unmet medical needs. Omeros concentrates on developing therapeutics with novel mechanisms of action that target previously untapped receptors and enzymes, aiming to provide next-generation treatments for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | |
| DEF 14A - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | |
| SCHEDULE 13G/A - OMEROS CORP (0001285819) (Subject) | 2026-03-27 | English | |
| 4 - OMEROS CORP (0001285819) (Issuer) | 2026-02-21 | English | |
| SCHEDULE 13G Filing | 2026-01-30 | English | |
| 4 Filing | 2026-01-14 | English |
Browse filings by year
23 years- 2026 7 filings
- 2025 36 filings
- 2024 29 filings
- 2023 39 filings
- 2022 51 filings
- 2021 37 filings
- 2020 45 filings
- 2019 47 filings
- 2018 36 filings
- 2017 44 filings
- 2016 67 filings
- 2015 45 filings
- 2014 45 filings
- 2013 50 filings
- 2012 42 filings
- 2011 34 filings
- 2010 49 filings
- 2009 39 filings
- 2008 12 filings
- 2007 2 filings
- 2006 2 filings
- 2005 1 filing
- 2004 4 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 39078996 | ARS - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | ||
| 39079103 | DEF 14A - OMEROS CORP (0001285819) (Filer) | 2026-04-30 | English | ||
| 33062212 | SCHEDULE 13G/A - OMEROS CORP (0001285819) (Subject) | 2026-03-27 | English | ||
| 32700252 | 4 - OMEROS CORP (0001285819) (Issuer) | 2026-02-21 | English | ||
| 28665560 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 28665570 | 4 Filing | 2026-01-14 | English | ||
| 28665565 | 8-K Filing | 2026-01-07 | English | ||
|
2025
8 filings
| |||||
| 11674670 | FORM 8-K | 2025-12-29 | English | ||
| 11674671 | FORM 8-K | 2025-12-01 | English | ||
| 11674672 | Regulatory Filings 2025 | 2025-11-14 | English | ||
| 11674673 | Regulatory Filings 2025 | 2025-11-14 | English | ||
| 11674674 | FORM 10-Q | 2025-11-13 | English | ||
| 11674675 | FORM 8-K | 2025-11-13 | English | ||
| 11674676 | Major Shareholding Notification 2025 | 2025-10-31 | English | ||
| 11674677 | FORM 4 | 2025-10-16 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
GUANGDONG VTR BIO-TECH CO., LTD.
Researches and manufactures biological enzyme preparations …
|
300381 | CN | Manufacturing |
|
Guangdong Zhongsheng Pharmaceutical Co.,Ltd.
High-tech firm specializing in TCM, chemical drugs, and bio…
|
002317 | CN | Manufacturing |
|
Guangxi Wuzhou Zhongheng Group Co.,Ltd
Produces modernized TCM pharmaceuticals and health-oriented…
|
600252 | CN | Manufacturing |
|
Guangyuyuan Chinese Herbal Medicine Co.,Ltd.
Historic TCM producer of high-end herbal medicines using tr…
|
600771 | CN | Manufacturing |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Vertically integrated pharmaceutical enterprise manufacturi…
|
874 | CN | Manufacturing |
|
Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Discovers and develops innovative therapies for metabolic a…
|
2591 | HK | Manufacturing |
|
Guangzhou LBP Medicine Science & Technology Co., Ltd.
Develops pathological diagnostic products and automated sys…
|
688393 | CN | Manufacturing |
|
GUANGZHOU WONDFO BIOTECH CO.,LTD
Develops and manufactures rapid diagnostic products and POC…
|
300482 | CN | Manufacturing |
|
Guerbet
Develops contrast media and medical devices for diagnostic …
|
GBT | FR | Manufacturing |
|
Gufic BioSciences Ltd.
Manufactures pharmaceutical formulations, APIs, and special…
|
GUFICBIO | IN | Manufacturing |
OMEROS CORP via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33369/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33369 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33369 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33369 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33369}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OMEROS CORP (id: 33369)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.